Search

everythinglearnresearchcommunity

for

Search:↓

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

AGA might indicate higher risk for severe COVID-19.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Baricitinib is effective and safe for treating severe alopecia areata.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Alefacept may effectively treat severe lichen planus, with patients showing significant improvement and no side effects.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Drinking alcohol before taking flibanserin does not increase the risk of severe low blood pressure or fainting.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Chemotherapy may help with survival in children with medulloblastoma, but more research is needed.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.